{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T11:05:48Z","timestamp":1787483148024,"version":"build-2736575974"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Novartis"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol Myers Squibb and Sanofi-Aventis"},{"name":"AstraZeneca"},{"name":"British Heart Foundation Centre of Research Excellence","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Few reports have examined the incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF) or their relationship with mortality in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with preserved ejection fraction (HFpEF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Data from the PARAGON-HF, TOPCAT, I-Preserve, and CHARM-Preserved trials were merged. VT\/VF, reported as adverse events, were identified. Patients who experienced VT\/VF were compared with patients who did not. The relationship between VT\/VF and mortality was examined in time-updated Cox proportional hazard regression models. Variables associated with VT\/VF were examined in Cox proportional hazard regression models. The rate of VT\/VF in patients with HFmrEF compared with patients with HFpEF was examined in a Cox proportional hazards regression model. Of 13 609 patients, over a median follow-up of 1170 days (interquartile range: 966\u20131451), 146 (1.1%) experienced an investigator-reported VT\/VF (incidence rate 0.3 per 100 person-years). Patients who experienced VT\/VF were more likely to be male, have had a myocardial infarction, poorer renal function, more adverse left ventricular remodelling, and higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) than patients who did not. Occurrence of VT\/VF was associated with NT-proBNP, history of atrial fibrillation\/flutter, male sex, lower ejection fraction, and history of hypertension. VT\/VF was associated with all-cause death [adjusted hazard ratio (HR): 3.95, 95% confidence interval (CI): 2.80\u20135.57; P &amp;lt; 0.001] and cardiovascular death, driven by death from heart failure and not sudden death. Patients with HFmrEF had a higher rate of VT\/VF than patients with HFpEF (adjusted HR: 2.19, 95% CI: 1.77\u20132.71).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>VT\/VF was uncommon in patients with HFmrEF and HFpEF. However, such events were strongly associated with mortality and appear to be a marker of disease severity rather than risk of sudden death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p>ClinicalTrials.gov unique identifier: NCT01920711(PARAGON-HF); NCT00094302 (TOPCAT); NCT00095238 (I-Preserve); NCT00634712 (CHARM-Preserved)<\/jats:p><\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac801","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T09:19:54Z","timestamp":1673515194000},"page":"668-677","source":"Crossref","is-referenced-by-count":25,"title":["Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction"],"prefix":"10.1093","volume":"44","author":[{"given":"James P","family":"Curtain","sequence":"first","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-7329","authenticated-orcid":false,"given":"Carly","family":"Adamson","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-7574","authenticated-orcid":false,"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad Haider","family":"Butt","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S","family":"Desai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital , 75 Francis Street, Boston, MA 02115 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Centre d'Investigations Cliniques Pluith\u00e9matique 1433 and Inserm U116 , CHRU, FCRIN INICRCT (Cardiovascular and Renal Trialists), Universit\u00e9 de Lorraine, 5 rue du Morvan 54500 Vandoeuvre-Les-Nancy , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L","family":"Rouleau","sequence":"additional","affiliation":[{"name":"Institut de Cardiologie de Montr\u00e9al, Universit\u00e9 de Montr\u00e9al , 5000, B\u00e9langer street, Montreal, H1T 1C8 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E","family":"Rohde","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Hospital Moinhos de Vento and Hospital de Clinicas de Porto Alegre, Medical School , UFRGS, Rua Ramiro Barcelos, 2400, Porto Alegre, RS 90.035-003 , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kober","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1308-4963","authenticated-orcid":false,"given":"Inder S","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Minnesota , 401 East River Parkway, VCRC 1st Floor, Suite 131, Minneapolis, MN 55455 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J","family":"van Veldhuisen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Groningen, University of Groningen , Postbus 30.001, 9700 RB, Groningen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Zile","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center , 109 Bee St, Charleston, SC 29401 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P","family":"Lefkowitz","sequence":"additional","affiliation":[{"name":"Novartis , 1 Health Plaza, East Hanover, NJ 07936 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital , 75 Francis Street, Boston, MA 02115 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2387","authenticated-orcid":false,"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute, Baylor University Medical Center , 3500 Gaston Avenue, Dallas, TX 75246 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-9496","authenticated-orcid":false,"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow G12 8TA , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008597","article-title":"Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF trial","volume":"14","author":"Desai","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000144474.65922.AA","article-title":"Effect of candesartan on cause-specific mortality in heart failure patients: the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program","volume":"110","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jchf.2018.02.014","article-title":"Sudden death in heart failure with preserved ejection fraction: a competing risks analysis from the TOPCAT trial","volume":"6","author":"Vaduganathan","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (I-preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ejhf.1970","article-title":"Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP-HF study","volume":"22","author":"van Veldhuisen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.hrthm.2020.05.038","article-title":"Sudden cardiac arrest with shockable rhythm in patients with heart failure","volume":"17","author":"Woolcott","year":"2020","journal-title":"Heart Rhythm"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/pace.14043","article-title":"Nonsustained ventricular tachycardia in heart failure with preserved ejection fraction","volume":"43","author":"Gutierrez","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"},{"key":"2023022023592960100_","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.2419","article-title":"Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF","volume":"24","author":"Curtain","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/8\/668\/49246396\/ehac801.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/8\/668\/49246396\/ehac801.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T18:58:20Z","timestamp":1679165900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/8\/668\/6985932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":12,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,2,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac801","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,21]]},"published":{"date-parts":[[2023,1,12]]}}}